Apigat® 2.5

Apigat® 2.5 is a crucial prescription medication containing 2.5 mg of the potent active ingredient, Apixaban. Classified as a Direct Oral Anticoagulant (DOAC) and a selective Factor Xa inhibitor, it is primarily prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Furthermore, it is a key therapy for the prevention and treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), especially following hip or knee replacement surgeries. By effectively interfering with the blood-clotting process, Apigat® 2.5 provides a vital, reliable, and convenient option for specialized stroke prevention and venous thromboembolism management, significantly enhancing patient safety and outcomes.